Why is Shenzhen Chipscreen Biosciences Co., Ltd. ?
1
Poor Management Efficiency with a low ROCE of 0%
- The company has reported losses and also has negative networth. This is not a good sign for the investors. Either company will have to raise fresh capital or report profits to sustain going forward
2
Poor long term growth as Net Sales has grown by an annual rate of 29.71% and Operating profit at -291.25% over the last 5 years
3
With a growth in Operating Profit of 141.72%, the company declared Outstanding results in Sep 25
- The company has declared positive results in Jan 70 after 2 consecutive negative quarters
- OPERATING CASH FLOW(Y) Highest at CNY 77.52 MM
- PRE-TAX PROFIT(Q) At CNY 48.27 MM has Grown at 2,552.93%
- NET PROFIT(Q) At CNY 41 MM has Grown at 538.37%
4
With ROE of -2.90%, it has a risky valuation with a 8.39 Price to Book Value
- Over the past year, while the stock has generated a return of 59.27%, its profits have risen by 60.4%
5
Market Beating Performance
- The stock has generated a return of 59.27% in the last 1 year, much higher than market (China Shanghai Composite) returns of 22.49%
How much should you buy?
- Overall Portfolio exposure to Shenzhen Chipscreen Biosciences Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Shenzhen Chipscreen Biosciences Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Shenzhen Chipscreen Biosciences Co., Ltd.
4.0%
0.90
54.82%
China Shanghai Composite
23.91%
1.58
14.20%
Quality key factors
Factor
Value
Sales Growth (5y)
26.40%
EBIT Growth (5y)
63.15%
EBIT to Interest (avg)
-4.81
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.58
Sales to Capital Employed (avg)
0.23
Tax Ratio
23.01%
Dividend Payout Ratio
46.36%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
1.36%
Valuation Key Factors 
Factor
Value
P/E Ratio
102
Industry P/E
Price to Book Value
3.86
EV to EBIT
74.16
EV to EBITDA
52.75
EV to Capital Employed
3.84
EV to Sales
9.96
PEG Ratio
0.56
Dividend Yield
0.24%
ROCE (Latest)
5.17%
ROE (Latest)
3.77%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
Technical Movement
32What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 122.06 MM
PRE-TAX PROFIT(Q)
At CNY 33.88 MM has Grown at 348.57%
NET PROFIT(Q)
At CNY 27.51 MM has Grown at 243.27%
NET SALES(Q)
At CNY 257.04 MM has Grown at 60.37%
RAW MATERIAL COST(Y)
Fallen by -5.33% (YoY
CASH AND EQV(HY)
Highest at CNY 2,312.34 MM
DEBT-EQUITY RATIO
(HY)
Lowest at 1.14 %
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for Shenzhen Chipscreen Biosciences Co., Ltd.
Pre-Tax Profit
At CNY 33.88 MM has Grown at 348.57%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (CNY MM)
Net Profit
At CNY 27.51 MM has Grown at 243.27%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (CNY MM)
Operating Cash Flow
Highest at CNY 122.06 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Net Sales
At CNY 257.04 MM has Grown at 60.37%
Year on Year (YoY)MOJO Watch
Near term sales trend is very positive
Net Sales (CNY MM)
Cash and Eqv
Highest at CNY 2,312.34 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debt-Equity Ratio
Lowest at 1.14 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Raw Material Cost
Fallen by -5.33% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales






